当前位置:主页 > 医学论文 > 中医论文 >

桂枝汤治疗胆碱能性荨麻疹患者的临床研究

发布时间:2018-09-17 15:01
【摘要】:目的通过桂枝汤治疗胆碱能性荨麻疹(Cholinergic urticaria,Ch U)患者临床症状的疗效观察,同时检测Ch U患者自体血清皮肤试验、自体汗液皮肤试验和血清中总Ig E水平的变化,对桂枝汤治疗胆碱能性荨麻疹的病理机制进行初步探讨。方法1.临床资料本组临床资料均来自于武汉周边某部队军人。2016年3月至2017年1月共我们收集胆碱能性荨麻疹合格调查问卷836份,其中符合胆碱能性荨麻疹诊断标准的患者69人,愿意全程参与本次实验的胆碱能性荨麻疹患者有20人。2.治疗和方法使用中药(口服桂枝汤每日1剂,每次150ml,早晚各1次)治疗胆碱能性荨麻疹患者30天,观察自体血清皮肤试验、自体汗液皮肤试验和血清中总Ig E的水平在口服桂枝汤的过程中,其治疗前、治疗15天、治疗30天后的变化。结果1.临床研究方面(1)经过15天的治疗后,观察临床疗效数据显示:15天治疗的总有效率为40%。经过30天的治疗后,观察临床疗效数据显示:30天治疗的总有效率为90%。治疗后15天症状积分下降指数(SSRI)与治疗后30天SSRI比较,差异有显著统计学意义(P0.05),治疗后30天SSRI较治疗后15天SSRI显著增加。(2)治疗后30天症状评分与治疗前症状评分相比,结果有显著统计学差异(P0.01),而治疗后15天症状评分与治疗前症状评分相比,结果无明显统计学差异(P0.05)。2.实验室研究方面(1)桂枝汤治疗胆碱能性荨麻疹患者,治疗前与治疗30天后,自体汗液皮肤试验结果有显著统计学差异(P0.01),而自体血清皮肤试验治疗前与治疗30天后相比,其结果无明显统计学差异(P0.05)。(2)治疗后30天的总Ig E水平与治疗前的总Ig E水平相比,结果有显著统计学差异(P0.05),而治疗后15天的总Ig E水平与治疗前总Ig E水平相比,结果无明显统计学差异(P0.05)。结论桂枝汤治疗胆碱能性荨麻疹有较好的临床疗效,桂枝汤能够调节胆碱能性荨麻疹患者出汗情况,减少风团的产生,减轻患者的临床症状,降低患者血清总Ig E水平,调节机体的免疫功能,从而提高胆碱能性荨麻疹患者的生活质量。
[Abstract]:Objective to observe the efficacy of Guizhi decoction in treating cholinergic urticaria (Cholinergic urticaria,Ch U), and to detect the changes of serum autogenous skin test, autologous sweat skin test and serum total Ig E level in patients with Ch U. The pathological mechanism of Guizhi decoction in the treatment of cholinergic urticaria was discussed. Method 1. From March 2016 to January 2017, we collected 836 qualified questionnaires for cholinergic urticaria, 69 of which met the diagnostic criteria of cholinergic urticaria. Twenty patients with cholinergic urticaria were willing to participate in the study. To treat cholinergic urticaria patients with cholinergic urticaria by traditional Chinese medicine (oral Guizhi decoction, 150 ml / day, 1 time in the morning and evening) for 30 days, and observe the skin test of autogenous serum. Autologous perspiration skin test and serum total Ig E levels in the course of oral administration of Guizhi decoction, the changes were observed before, 15 days and 30 days after treatment. Result 1. In clinical studies (1) after 15 days of treatment, the observation of clinical efficacy data showed that the total effective rate of 15 days treatment was 40%. After 30 days of treatment, the clinical efficacy data showed that the total effective rate of 30 days treatment was 90. The decrease index of symptom score (SSRI) on day 15 after treatment was significantly higher than that on day 30 after treatment (P0.05), and SSRI on day 30 after treatment was significantly higher than that on day 15 after treatment. (2) symptom score at day 30 after treatment was significantly higher than that at day 30 after treatment. Results there was significant statistical difference (P0.01), but there was no significant difference between the symptom score of 15 days after treatment and the pre-treatment symptom score (P0.05). 2. In laboratory studies, (1) there was a significant difference in the results of autologous sweat skin test before and after 30 days of treatment in patients with cholinergic urticaria treated with Guizhi decoction (P0.01), but there was a significant difference between before and after 30 days of treatment with the autologous serum skin test. The results showed that there was no significant difference (P0.05). (2) between the total Ig E level 30 days after treatment and the total Ig E level before treatment (P0.05), while the total Ig E level 15 days after treatment was compared with the total Ig E level before treatment. Results there was no significant statistical difference (P0.05). Conclusion Guizhi decoction has a good clinical effect on cholinergic urticaria. Guizhi decoction can regulate the sweating condition of cholinergic urticaria patients, reduce the formation of wind mass, alleviate the clinical symptoms of patients, and reduce the serum total Ig E level of patients with cholinergic urticaria. Adjusts the body's immune function, thus improves the cholinergic urticaria patient's quality of life.
【学位授予单位】:湖北中医药大学
【学位级别】:硕士
【学位授予年份】:2017
【分类号】:R275.9

【参考文献】

相关期刊论文 前10条

1 陆晓霏;马剑辉;张云海;;梅山地区520例30~60岁慢性荨麻疹患者的流行病学分析[J];现代医学;2017年01期

2 陈瑞;晏洪波;马俊;马大宝;;驻鄂某部队官兵胆碱能性荨麻疹流行病学调查及特征分析[J];实用皮肤病学杂志;2015年06期

3 陆杰;;桂枝汤的现代应用研究[J];中国医药指南;2015年27期

4 徐颖;杨艳;高丽丽;;磷酸组织胺脱敏联合H1 H2抗体阻滞剂治疗皮肤划痕症疗效观察[J];河北医学;2014年11期

5 赵广海;;桂枝汤临床应用及其药理学作用[J];内蒙古中医药;2014年01期

6 杨春;;从桂枝汤对汗液分泌的双向调节作用论治杂症体会[J];中医研究;2011年06期

7 赖维;谢小元;龚子鉴;叶张章;;荨麻疹:欧洲2009年指南和2006年指南的比较[J];皮肤性病诊疗学杂志;2010年03期

8 殷越;刘威;;桂枝汤双向调节作用的研究进展(二)[J];中医药信息;2009年06期

9 陈明春;李丹;郭庆;曾凡钦;;慢性荨麻疹临床表现与ASST的关系研究[J];中国热带医学;2008年05期

10 陈文华;;桂枝汤治疗荨麻疹的疗效分析[J];中国现代医生;2007年19期

相关博士学位论文 前1条

1 刘新亚;桂枝汤证治规律及桂枝汤对大鼠体液免疫和细胞免疫干预作用的研究[D];广州中医药大学;2005年

相关硕士学位论文 前1条

1 罗婕;慢性荨麻疹临床流行病学研究[D];第三军医大学;2012年



本文编号:2246280

资料下载
论文发表

本文链接:https://www.wllwen.com/zhongyixuelunwen/2246280.html


Copyright(c)文论论文网All Rights Reserved | 网站地图 |

版权申明:资料由用户adaac***提供,本站仅收录摘要或目录,作者需要删除请E-mail邮箱bigeng88@qq.com